https://www.selleckchem.com/pr....oducts/dl-buthionine
ts. Our experience provides a strong foundation for designing specialized systems to promote individualized transplant follow-up care. To our knowledge, this is the first study of a comprehensive DLI-CDSS for kidney transplant care. By alerting on considerations in renal and hepatic dysfunctions, maternal and fetal toxicity, or required lab monitoring, this system can potentially improve medication safety in kidney recipients. Our experience provides a strong foundation for designing specialized systems to promote indi
Like
Comment
Share
